Clinical trial
Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease Patients
NCT05635474 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease Patients
- Lead sponsor
- Taipei Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 25, 2022
- Completion date
- May 31, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
effects of bacillus coagulans tci711 supplementation on liver and gut microbiota function in non-alcoholic fatty liver disease patients